Cargando…
Bone-Targeted Extracellular Vesicles from Mesenchymal Stem Cells for Osteoporosis Therapy
BACKGROUND: Current drugs used for osteoporosis therapy show strong adverse effects. Stem cell-derived extracellular vesicles (EVs) provide another choice for osteoporosis therapy. Mouse mesenchymal stem cells (mMSCs)-derived EVs promote bone regeneration; however, their clinical application is limi...
Autores principales: | Wang, Yayu, Yao, Jie, Cai, Lizhao, Liu, Tong, Wang, Xiaogang, Zhang, Ye, Zhou, Zhiying, Li, Tingwei, Liu, Minyi, Lai, Renfa, Liu, Xiangning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573321/ https://www.ncbi.nlm.nih.gov/pubmed/33116512 http://dx.doi.org/10.2147/IJN.S263756 |
Ejemplares similares
-
Study of a new bone-targeting titanium implant–bone interface
por: Liu, Xiangning, et al.
Publicado: (2016) -
Prospective applications of extracellular vesicle-based therapies in regenerative medicine: implications for the use of dental stem cell-derived extracellular vesicles
por: Wang, Wenhao, et al.
Publicado: (2023) -
miR-146a-5p targets Sirt1 to regulate bone mass
por: Zheng, Mingxia, et al.
Publicado: (2021) -
Mesenchymal Stem Cell-Derived Extracellular Vesicle: A Promising Alternative Therapy for Osteoporosis
por: Lu, Cheng-Hsiu, et al.
Publicado: (2021) -
Vascular Pericyte-Derived Exosomes Inhibit Bone Resorption via Traf3
por: Cai, Mingxiang, et al.
Publicado: (2023)